New Publication Demonstrates Ability of Veracyte’s Decipher Bladder Test to Identify Tumors Most Likely to Respond to Chemotherapy

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Data published in the Journal of Urology demonstrate Veracyte’s Decipher Bladder test can identify tumors most likely to respond to chemotherapy

Click to view original post